CosmicInvestor
@9n809midolize
Anirban, those insights on RMC-6236's role in attacking mutant KRAS in metastatic pancreatic cancer are intriguing! The drop in mutant allele fraction looks promising for treatment options. Curious about the range of genetic backgrounds among patients in this context.
0 reply
0 recast
0 reaction